YKL183C-A Antibody

What is YKL183C-A Antibody and what organism does it target?

YKL183C-A Antibody is a polyclonal antibody raised in rabbits that specifically targets the YKL183C-A protein from Saccharomyces cerevisiae (strain ATCC 204508 / S288c), commonly known as Baker's yeast. The antibody is generated using a recombinant YKL183C-A protein immunogen and is purified through antigen affinity chromatography. This antibody is specifically designed for research applications involving S. cerevisiae and has been validated for use in techniques such as ELISA and Western Blotting. YKL183C-A Antibody allows researchers to detect and study the corresponding yeast protein in various experimental contexts, providing valuable insights into yeast cellular processes .

What are the validated applications for YKL183C-A Antibody?

YKL183C-A Antibody has been validated for multiple research applications with specific protocols:

These applications allow researchers to detect and quantify YKL183C-A protein in various experimental settings. When using this antibody for Western Blotting, it's particularly important to ensure proper sample preparation and to include appropriate positive and negative controls to validate specificity .

What are the optimal storage conditions for YKL183C-A Antibody?

Proper storage of YKL183C-A Antibody is crucial for maintaining its activity and specificity. Upon receipt, the antibody should be stored at -20°C or -80°C for long-term preservation. For short-term use, storage at 4°C is acceptable, but repeated freeze-thaw cycles should be avoided as they can degrade antibody quality and performance. The antibody is supplied in a storage buffer containing 0.03% Proclin 300 as a preservative, 50% Glycerol, and 0.01M PBS at pH 7.4. This formulation helps maintain antibody stability during storage. When working with the antibody, it's recommended to prepare aliquots upon first thawing to minimize freeze-thaw cycles. Proper storage is essential for ensuring consistent experimental results and extending the shelf-life of this research reagent .

How can I validate the specificity of YKL183C-A Antibody in my yeast strain of interest?

Validating antibody specificity is essential for ensuring reliable experimental results. For YKL183C-A Antibody, employ the following comprehensive validation strategy:

• Genetic validation approach: This represents the gold standard for antibody validation. Create a YKL183C-A knockout strain in your yeast model using CRISPR-Cas9 or traditional homologous recombination methods. The antibody should show no signal in this knockout strain when compared to wild-type controls. This approach aligns with recommendations from the International Working Group for Antibody Validation .

• Expression system controls: Generate recombinant expression systems that either overexpress YKL183C-A or express tagged versions of the protein. Compare antibody signal intensity with expression levels to confirm proportional detection.

• Cross-reactivity assessment: Test the antibody against closely related yeast strains or species to determine potential cross-reactivity with homologous proteins. This is particularly important when working with non-S288c strains.

• Immunoprecipitation followed by mass spectrometry: Use the antibody for immunoprecipitation, then analyze the precipitated proteins by mass spectrometry to confirm that YKL183C-A is the predominant protein detected.

• Western blot analysis with peptide competition: Pre-incubate the antibody with excess purified YKL183C-A protein or immunogenic peptide before Western blotting. The specific signal should be significantly reduced or eliminated.

Remember that absence of evidence is not evidence of absence - a negative result might indicate either lack of target protein or insufficient antibody sensitivity .

What are the recommended troubleshooting steps when YKL183C-A Antibody shows weak or no signal in Western blots?

When encountering weak or absent signals with YKL183C-A Antibody in Western blot applications, implement this systematic troubleshooting approach:

• Sample preparation optimization:

  • Ensure complete cell lysis using appropriate buffers containing protease inhibitors

  • Optimize protein extraction conditions for yeast cells (consider enzymatic cell wall digestion)

  • Verify protein concentration using Bradford or BCA assays

  • Use fresh samples; avoid degraded material

• Protocol optimization:

  • Adjust antibody concentration (try a dilution series from 1:250 to 1:2000)

  • Increase incubation time (overnight at 4°C may improve signal)

  • Modify blocking conditions (try 5% BSA instead of milk if phosphorylated epitopes are suspected)

  • Optimize transfer conditions for high or low molecular weight proteins

  • Use PVDF membranes for potentially better protein retention

• Signal detection enhancements:

  • Use a more sensitive detection system (chemiluminescent or fluorescent)

  • Increase exposure time for chemiluminescent detection

  • Consider signal amplification methods

• Protein expression verification:

  • Confirm YKL183C-A expression under your specific experimental conditions

  • Use appropriate positive controls (recombinant YKL183C-A protein)

  • Consider if experimental conditions might alter protein expression

• Antibody validation:

  • Test antibody activity with a known positive control

  • Verify antibody hasn't degraded over time or through improper storage

  • Consider using a different lot or alternative antibody if available

How does YKL183C-A Antibody differ from other YKL-family antibodies like YKL-40 and YKL-39?

While YKL183C-A, YKL-40, and YKL-39 antibodies all target proteins with "YKL" nomenclature, they recognize fundamentally different proteins with distinct biological functions and origins:

The nomenclature similarity is somewhat misleading, as these proteins belong to entirely different biological systems - YKL183C-A is a yeast protein, while YKL-40 and YKL-39 are human proteins involved in inflammation and cancer pathways, respectively. Research questions involving YKL-40 and YKL-39 typically focus on human disease mechanisms, while YKL183C-A research is primarily relevant to yeast biology and potentially fungal model systems .

What considerations are important when investigating potential homology between yeast YKL183C-A and human YKL-family proteins?

When investigating potential evolutionary relationships or functional homology between yeast YKL183C-A and human YKL-family proteins (such as YKL-40/CHI3L1 or YKL-39/CHI3L2), researchers should consider several critical aspects:

While yeast and human YKL-family proteins share nomenclature elements, human YKL-40 and YKL-39 are chitinase-like proteins with complex roles in inflammation, immune regulation, and angiogenesis. Conversely, yeast YKL183C-A's function appears distinct, reflecting the vast evolutionary distance between these organisms. Any homology studies should account for both potential convergent evolution of functions and divergent evolution from ancient common ancestors .

What are the optimal protein extraction methods from yeast cells to maximize YKL183C-A detection?

Extracting yeast proteins for YKL183C-A detection requires specialized protocols to overcome the robust cell wall and ensure protein integrity. The following methodological approaches maximize detection sensitivity:

• Mechanical disruption with glass beads:

  • Resuspend yeast cells in lysis buffer containing protease inhibitors

  • Add acid-washed glass beads (0.5mm diameter)

  • Vortex vigorously in 30-second bursts (8-10 cycles) with cooling on ice between cycles

  • Centrifuge at 12,000g for 10 minutes to remove cell debris

  • Collect supernatant containing soluble proteins

• Enzymatic cell wall digestion:

  • Create spheroplasts using lyticase or zymolyase (5-10 units per OD600 of cells)

  • Incubate at 30°C for 30-60 minutes until >80% spheroplasting is achieved

  • Gently lyse spheroplasts with mild detergent buffer

  • Avoid excess heat generation during processing

• Optimized lysis buffer composition:

  • Base buffer: 50mM Tris-HCl pH 7.5, 150mM NaCl

  • Detergents: 1% Triton X-100 or 0.1% SDS

  • Protease inhibitors: Complete protease inhibitor cocktail (1X)

  • Phosphatase inhibitors: 1mM sodium orthovanadate, 5mM sodium fluoride

  • Reducing agents: 1mM DTT or 5mM β-mercaptoethanol

  • EDTA: 1mM to chelate metal ions

• Protein precipitation and concentration:

  • TCA precipitation (10-20% final concentration) for dilute samples

  • Acetone precipitation (4 volumes) at -20°C overnight

  • Resuspend precipitated proteins in appropriate buffer for downstream applications

This optimized extraction approach significantly improves YKL183C-A detection in Western blot and ELISA applications by maximizing protein yield while preserving epitope integrity .

What positive and negative controls should be included when using YKL183C-A Antibody in experimental workflows?

Incorporating appropriate controls is essential for interpreting results with YKL183C-A Antibody. The following comprehensive control strategy ensures experimental rigor:

Positive Controls:

• Recombinant YKL183C-A protein: Include purified recombinant protein (as used in immunogen preparation) as a size and reactivity reference.

• Wild-type S. cerevisiae S288c lysate: The strain specifically listed in the antibody specifications should show clear detection of endogenous YKL183C-A.

• YKL183C-A overexpression samples: Yeast strains engineered to overexpress the target provide valuable positive signal reference.

• Growth condition controls: Samples from conditions known to induce YKL183C-A expression, if such conditions are documented in literature.

Negative Controls:

• YKL183C-A knockout/deletion strain: A genetically engineered strain lacking the target gene provides the most definitive negative control.

• Distantly related yeast species: Non-target species help assess non-specific binding.

• Primary antibody omission control: Process samples identically but omit primary antibody to detect secondary antibody non-specific binding.

• Isotype control: Use non-specific rabbit IgG at the same concentration as YKL183C-A Antibody to identify background signal.

• Peptide competition: Pre-incubate antibody with excess immunizing peptide to demonstrate binding specificity.

Technical Controls:

• Loading control antibodies: Include antibodies against constitutively expressed yeast proteins (e.g., GAPDH, actin, tubulin) to normalize loading.

• Molecular weight markers: Use precision markers spanning appropriate size ranges.

• Secondary antibody-only lanes: Identify non-specific secondary antibody binding.

Carefully documented controls not only validate experimental results but also comply with increasing journal requirements for antibody validation standards .

How should researchers interpret cross-reactivity when YKL183C-A Antibody shows signal in non-target species?

When YKL183C-A Antibody produces signals in non-target species or strains, careful analytical interpretation is required to distinguish meaningful cross-reactivity from experimental artifacts:

• Systematic cross-reactivity analysis:

  • Evaluate the signal pattern across multiple independent experiments

  • Compare band molecular weights between target and non-target species

  • Assess signal intensity ratios between species under identical conditions

  • Document all experimental parameters that might influence cross-reactivity

• Biological interpretation framework:

  • Homologous proteins: Cross-reactivity may indicate conserved epitopes in homologous proteins. Perform sequence alignment analysis to identify potential homologs in the non-target species.

  • Convergent epitopes: Structurally similar epitopes can exist in functionally unrelated proteins. Consider structural prediction tools to identify potential mimics.

  • Post-translational modifications: Consider whether modifications create epitopes that resemble the target.

• Validation approaches for unexpected cross-reactivity:

  • Immunoprecipitation followed by mass spectrometry to identify the cross-reactive protein

  • Peptide competition assays using both target and suspected cross-reactive peptides

  • Genetic approaches (knockdown/knockout) in the non-target species to confirm specificity

  • Western blotting with alternative antibodies against the same target

• Reporting guidelines:

  • Document all observed cross-reactivity in publications

  • Specify exact conditions under which cross-reactivity occurs

  • Include images of cross-reactivity for transparent reporting

Cross-reactivity, while often viewed as problematic, can occasionally reveal unexpected biological relationships between proteins. This approach to interpretation aligns with established antibody validation frameworks recommended in the literature .

What factors should be considered when analyzing quantitative differences in YKL183C-A levels across experimental conditions?

When analyzing quantitative differences in YKL183C-A levels across experimental conditions, researchers should consider multiple technical and biological factors to ensure valid interpretation:

• Technical considerations for quantitative analysis:

  • Linear detection range: Ensure signal intensities fall within the linear dynamic range of your detection method

  • Saturation effects: Overexposed Western blots cannot be reliably quantified

  • Loading normalization: Always normalize to appropriate housekeeping proteins or total protein stains

  • Replicate consistency: Evaluate coefficient of variation between technical replicates (<15% is typically acceptable)

  • Batch effects: Control for differences between experimental batches

• Statistical analysis framework:

  • Apply appropriate statistical tests based on data distribution

  • Consider multiple testing corrections when analyzing many conditions

  • Report effect sizes alongside p-values

  • Use power calculations to ensure sufficient biological replicates

• Biological interpretation matrix:

  Observation	Potential Biological Meaning	Validation Approach
  Increased YKL183C-A levels	Enhanced gene expression, Protein stabilization, Reduced degradation	qRT-PCR for mRNA levels, Pulse-chase experiments, Proteasome inhibition studies
  Decreased YKL183C-A levels	Reduced gene expression, Enhanced protein degradation, Secretion/relocalization	Transcript analysis, Subcellular fractionation, Degradation pathway analysis
  Modified migration pattern	Post-translational modifications, Alternative splicing, Proteolytic processing	Phosphatase treatment, Glycosidase digestion, Mass spectrometry
  Multiple bands	Isoforms, Degradation products, Non-specific binding	Immunoprecipitation + MS, Blocking peptides, Alternative antibodies

• Experimental design controls:

  • Include time-course analysis to capture dynamic changes

  • Consider dose-response relationships when applicable

  • Evaluate subcellular localization alongside total protein levels

  • Account for cell cycle effects in proliferating yeast cultures